Department of Pharmaceutics, King Saud University, Riyadh, Kingdom of Saudi Arabia
Research Article
Extemporaneous Compounding of Furosemide Oral Liquid Formulations: A Systemic Review
Author(s): Imraan Joosub*, Mohammed Al-Anezi, Zohair Emara and Eman Youssif
Small-scale compounding of oral liquid dosage forms lacks long-term safety and efficacy data of commercially available
medicines. Medication shortages of furosemide syrup continue to burden healthcare treatment. Extemporaneous
compounding of commercially available registered drugs is prohibited, except under exceptional circumstances.
Compounding an alcohol-free furosemide oral liquid may be safe for pediatric patients. This study aims to alleviate
a nationwide shortage of furosemide syrup via a literature review of extemporaneous compounding resources.
Investigators performed a literature review and found that 8 of the 13 stability studies of furosemide oral liquids were
alcohol-free with at least a 30-day shelf life, and may be suitably compounded for pediatric patients. In the absence
of a commercially available furosemide syrup, this review found safe alternat.. View more»